Immunotoxin therapy for CNS tumor
Copyright policy )Immunotoxin therapy for CNS tumor
Surgery, chemotherapy, and radiation therapy have become standard of practice in treating malignant brain tumors. Unfortunately, the prognosis of these malignant tumors still remains poor. Immunotoxins are a relatively new adjuvant treatment for brain tumors. Within the last few years an increased amount of clinically-oriented research involving immunotoxins has been published. This has led to numerous clinical trials which although encouraging have not yet born out the "magic bullet" concept envisioned for immunotoxins. In this review article the history, design, toxicity, and pharmokinetics of immunotoxins will be discussed in detail.
- University of Minnesota United States
- University of Minnesota Morris United States
Central Nervous System Neoplasms, Immunotoxins, Injections, Intravenous, Animals, Humans, Receptors, Cell Surface, Antigens, Injections, Intralesional, Injections, Spinal
Central Nervous System Neoplasms, Immunotoxins, Injections, Intravenous, Animals, Humans, Receptors, Cell Surface, Antigens, Injections, Intralesional, Injections, Spinal
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).31 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!